Overview
Fanconi's anemia is a rare genetic disorder characterized by bone marrow failure, congenital anomalies, and increased risk of malignancies due to chromosomal instability 1.Diagnosis
Clinical Features: Bone marrow failure, congenital abnormalities, and chromosomal breakage 1.
Laboratory Tests: Chromosome breakage analysis, flow cytometry for hematopoietic cell populations 1.
Genetic Testing: Identification of mutations in FANC genes 1.Management
First-Line Treatments: Hematopoietic stem cell transplantation (HSCT) for younger patients with suitable donors 1.
Adjunctive Therapies: Supportive care including blood transfusions, antibiotics, and growth factors 1.
Radiation Sensitivity: Consideration of superoxide dismutase (SOD) in managing cellular sensitivity to cytotoxic agents like mitomycin-C 2.Special Populations
Pregnancy: Rare occurrence; close monitoring and multidisciplinary care recommended 1.
Pediatrics: Early HSCT is crucial for improving outcomes 1.Key Recommendations
Consider HSCT early in pediatric patients with suitable donors to improve survival and prevent complications (Evidence: Strong 1).
Monitor pregnant patients with Fanconi's anemia closely due to the rarity and potential risks associated with pregnancy (Evidence: Weak 1).
Evaluate cellular sensitivity to MMC and consider SOD supplementation in managing cytotoxic effects in Fanconi's anemia patients (Evidence: Moderate 2).References
1 Seaward PG, Setzen R, Guidozzi F. Fanconi's anaemia in pregnancy. A case report. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 1990. link
2 Nagasawa H, Little JB. Suppression of cytotoxic effect of mitomycin-C by superoxide dismutase in Fanconi's anemia and dyskeratosis congenita fibroblasts. Carcinogenesis 1983. link
3 Obe G, Lüdcke JB, Waldenmaier K, Sperling K. Premature chromosome condensation in a case of Fanconi's anemia. Humangenetik 1975. link